Prudential Financial Inc Rocket Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$20.66 - $26.72 $1.22 Million - $1.57 Million	-58,925 Reduced 36.46%	102,705 $2.21 Million
Q1 2024 May 14, 2024	BUY	$26.16 - $30.74 $3.03 Million - $3.57 Million	115,973 Added 254.01%	161,630 $4.35 Million
Q4 2023 Feb 13, 2024	BUY	$16.78 - $31.94 $766,124 - $1.46 Million	45,657 New	45,657 $1.37 Million
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $258,389 - $367,570	15,575 New	15,575 $309,000
Q1 2021 May 12, 2021	SELL	$43.34 - $65.91 $169,459 - $257,708	-3,910 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $91,103 - $232,918	3,910 New	3,910 $214,000

210

93.1M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $813M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.